Cargando…
Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes
Autores principales: | Hafner, Roderick, Couroux, Peter, Armstrong, Kristen, Patel, Deepen, Larche, Mark, Haumann, Brett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716539/ http://dx.doi.org/10.1186/2045-7022-3-S2-O7 |
Ejemplares similares
-
Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses
por: Hafner, Roderick Peter, et al.
Publicado: (2013) -
Cats and Allergies
Publicado: (2005) -
Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
por: Hafner, Roderick Peter, et al.
Publicado: (2013) -
The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy
por: Neighbour, Helen, et al.
Publicado: (2018) -
Molecular diagnosis in cat allergy
por: Popescu, Florin-Dan, et al.
Publicado: (2021)